Pentixapharm AG vs RayzeBio
Pentixapharm AG
improves the life of patients with malignant diseases through targeted molecular diagnostic and therapy
33 employees · est. 2019 · Berlin, Germany
RayzeBio
Targeted innovative radiopharmaceuticals for cancer
258 employees · est. 2020 · San Diego, United States
Pentixapharm AG is the older company (2019 vs 2020); RayzeBio is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Pentixapharm AG | RayzeBio |
|---|---|---|
| Founded | ||
| Founded | 2019 older | 2020 |
| Headquarters | ||
| Headquarters | Berlin, Germany | San Diego, United States |
| Employees | ||
| Employees | 33 | 258 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biotechnology, Health Care, Medical Devices |
| Funding Stage | ||
| Funding Stage | Series A | Acquired |
| Total Funding | ||
| Total Funding | $15.00M | $4.78B |
| Funding Rounds | ||
| Funding Rounds | 2 | 5 |
| Services | ||
| Services | Development of first-in-class radiopharmaceutical compounds, Phase-III clinical trial management, Advanced PET-Diagnostics for medical conditions | Development of radiopharmaceutical therapies, Precision cancer treatment using actinium-225, Manufacturing of pharmaceutical products, Clinical trial capabilities, Drug discovery and development |
| Target Customers | ||
| Target Customers | Medical Institutions, Healthcare Professionals, Patients with Hemato-Oncological Conditions | Cancer patients, Oncologists, Healthcare providers, Research institutions, Pharmaceutical companies |
| Taxonomy | ||
| Taxonomy | Theranostic RadiopharmaceuticalsMolecular DiagnosticsOncologyRadiopharmaceutical DevelopmentCXCR4-receptor TargetingCNS Lymphoma +6 | RadiopharmaceuticalsCancer TreatmentTargeted TherapiesRadioisotopesAlpha ParticlesActinium-225 +8 |
| Website | ||
| Website | pentixapharm.com | rayzebio.com |
About Pentixapharm AG
Pentixapharm AG is a biotechnology company founded in 2019 and headquartered in Germany. The company is committed to enhancing the lives of patients with malignant diseases by delivering targeted molecular diagnostics and therapies, encapsulated in its slogan: "improves the life of patients with mal...
About RayzeBio
RayzeBio, founded in 2020, is a cutting-edge player in the Biotechnology and Pharmaceutical sectors, focusing on the development of targeted innovative radiopharmaceuticals for cancer treatment. With a mission outlined in their slogan, "Targeted innovative radiopharmaceuticals for cancer," RayzeBio...
Also comparing in this category
Comparing more than these two?
Get Pentixapharm AG, RayzeBio and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Pentixapharm AG compare?
A PDF of Pentixapharm AG and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Pentixapharm AG with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Pentixapharm AG on 14 May 2026, and RayzeBio on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.